Skip to Main Content

Brain Imaging Research Study

  • Study HIC#:2000028664
  • Last Updated:02/22/2024

If you are between the ages of 65-85 years old, you may be eligible to participate in a brain imaging research study. No medications or radioactivity. 

Compensation up to $130.

If you are interested in participating, or if you have any questions, please call 203-974-7891 or email: shefali.chaudhary@yale.edu and mention "aging study".

  • Age65 years - 85 years
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Shefali Chaudhary, PhD

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Trial Purpose and Description

If you are between the ages of 65-85 years old, you may be eligible to participate in a brain imaging research study. No medications or radioactivity. 

Compensation up to $130.

If you are interested in participating, or if you have any questions, please call 203-974-7891 or email: shefali.chaudhary@yale.edu and mention "aging study".

Eligibility Criteria

Inclusion Criteria:

1) Between ages 65 and 85 years old.

Exclusion Criteria:

1) Current or history of diagnosis of psychotic or substance (except nicotine and alcohol) use disorders or current diagnosis of major depressive disorder according to DSM-IV criteria (SCID).

2) Individuals who meet the cutoff score of severe depression (≥ 29) on the Beck Depression Inventory-II.

3) Current use of any psychoactive drugs including anxiolytics and antidepressants.

4) Significant, uncontrolled current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology (controlled diabetes, hypertension and hypothyroidism are allowed).

5) History of neurological illnesses or brain injury with loss of consciousness.

6) History of a cerebrovascular event including transient ischemic attack.

7) Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications (e.g., claustrophobia) will be excluded.

8) Women who are pregnant or nursing.

9) For HIV infected patients, elite controllers and those not on antiretroviral therapy will be excluded.

10) For HIV infected patients, those with history of or current CNS opportunistic infection will be excluded.

Principal Investigator

Sub-Investigators

For more information about this study, including how to volunteer, contact: